New Zealand approves use of ‘magic mushrooms' to treat depression but only one psychiatrist is allowed to prescribe it
David Seymour, New Zealand's associate minister of health, said on Wednesday that the rules have been relaxed on the use of Psilocybin in the country for the first time but only a highly experienced psychiatrist has been allowed to prescribe it to patients.
He said the new policy is a 'real breakthrough' even as the drug remains 'an unapproved medicine'.
'Psilocybin remains an unapproved medicine, but a highly experienced psychiatrist has been granted authority to prescribe it to patients with treatment-resistant depression,' Mr Seymour said.
'This is huge for people with depression who've tried everything else and are still suffering.
'If a doctor believes psilocybin can help, they should have the tools to try.'
The psychiatrist, Cameron Lacey, who was behind the first clinical trials of psilocybin, has been identified as the only medical practitioner to prescribe the drug.
The professor at the University of Otago 'has previously prescribed psilocybin in clinical trials and will operate under strict reporting and record-keeping requirements', Mr Seymour said.
Mr Lacey told RNZ that it had taken "a long time, a lot of energy and perseverance' to get the approval.
New Zealand also announced plans to allow the use of melatonin, which is used to help with insomnia and allow its over-the-counter sale as the policy change on psilocybin was announced.
'Many New Zealanders have asked me why people can buy melatonin overseas but they can't buy it from their local pharmacy. Medsafe has assessed this and decided there's no reason why it shouldn't be available on pharmacy shelves right here at home,' Mr Seymour said.
Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms, commonly known as 'magic mushrooms'. Found in over 180 species of fungi these mushrooms have a long history of use in Indigenous spiritual and healing rituals in parts of Central and South America.
Studies have found that 80 per cent of patients who were given psilocybin experienced a drop in anxiety and depression that lasted for six months or more.
New Zealand has become the latest country to allow the use of Psilocybin.
In 2023, Australia allowed some psychiatrists to prescribe the drug for the treatment of certain mental health conditions.
In the US, only while some states allow restricted access to the drug.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
4 hours ago
- Telegraph
More than 1.4m claiming mental health benefits
A record 531 people a day were granted welfare benefits for mental health problems, analysis of last year's Personal Independence Payment (Pip) figures reveals. In the 2024-25 financial year, Department for Work and Pensions staff approved 193,890 such cases for England and Wales – equivalent to one application being rubber-stamped every three minutes. The full extent of those claiming Pip due to mental health illness could in fact be much higher because the Government data do not include those who successfully appeal an initial rejection of their claim. The latest statistics for the month of April also reveal that a total of 1.4 million people were in receipt of a Pip payment due to mental health issues. That figure represents a 70 per cent increase compared to a similar monthly snapshot taken in January 2020 when 848,882 such payments were approved. That April data includes 407,000 cases approved for 'mixed anxiety and depression', 62,000 for 'anxiety disorders' and 83,000 for ADHD, alongside a variety of other illnesses ranging from autism to personality disorders. Meanwhile, one in 10 of the country's 38 million working-age people is in receipt of some kind of health benefit. In November 2024, 3,943,677 people aged between 16 and 64 were claiming some form of payment for disability or sickness. Reform UK's Richard Tice MP said: 'The level of waste and corruption in this country is at an all-time high, with a total lack of oversight, massive overspending, and no accountability from this Labour government. 'This country needs to be run more like a business and less like a charity with unlimited funding. It's always the hard-working British taxpayer who ends up paying the price. 'Reform will slash government spending by scrapping net zero, ending DEI practices, and securing our borders. By doing so, we will free up funds to focus on what truly matters: improving public services and easing the burden on the working class.' Helen Whately, the shadow work and pensions secretary, said: 'This week, the Prime Minister was forced into a humiliating climbdown on welfare by socialist Labour MPs. 'Runaway welfare spending has to be brought under control, but unbelievably we're now left with a Bill that will end up costing the taxpayer more. 'Starmer is in office, but not in power. And without someone able to take difficult decisions, this country is doomed.' The analysis comes just days after Labour backbenchers forced Rachel Reeves to back down on her plans to cut the benefits bill. The Chancellor had hoped to impose more stringent disability criteria for Pip claimants to help fill a black hole in the Government's spending forecasts. But on Thursday, she was forced into a £3 billion U-turn to placate rebel MPs. As part of the deal, the restriction will only affect new claimants, while those already on the benefit will continue to receive it. The move has raised the prospect of tax rises in the autumn budget. There has been speculation that the fiasco surrounding the reversal and its financial repercussions may have contributed to Ms Reeves' tears in the House of Commons on Wednesday. Analysis of Government data shows that since January 2020, the number of Pip cases for mental health problems has soared considerably faster than for other ailments. Overall Pip claims have increased by 55 per cent, whilst those citing mental health have increased by 70 per cent. Last year, the government spent £26.5 billion on the benefit, including around £3.5 billion for anxiety, ADHD and depression alone. By 2029-30, the total cost is expected to approach £35 billion, according to the Department for Work and Pensions. Telegraph analysis found that around 8.5 per cent of the working-age population are on either Pip or its immediate predecessor, the disability living allowance (DLA). This is up from 4.4 per cent in 2002. Once other disability benefits are included, such as attendance allowance or employment and support allowance, this increases to 10.3 per cent of the working-age population being on some form of sickness or disability support. Of particular concern is the rise in disability benefits being awarded to young adults. Around 5.8 per cent of people aged 16 to 30 now claim either Pip or DLA, up from just 1.7 per cent in 2002. More than one in 25 young adults (4.4 per cent) are claiming for mental health. The vast range of Pip payments, including obscure ones, has also caused concern. In April alone, a total of 10 payouts were awarded for 'Munchausen syndrome', 67 for food intolerance, 16 for 'old age' and almost 17,000 for alcohol and drug misuse. In 2024-25, an average of 2,656 new registrations for Pip were made everyday in England and Wales, with about 1,262 of those claims then being approved. Of those, an average of 531 a day were for psychiatric disorders, 341 for bone and joint issues and 121 for neurological disorders.
BBC News
7 hours ago
- BBC News
Gloucester 'crazy' challenge in support of men's mental health
A man is taking on a "crazy" challenge completing a marathon in his wheelchair on a set of rollers to raise awareness for men's mental Hampton, from Gloucester, is taking on the challenge at Everlast Gym, in Cheltenham on Saturday, teaming up with Gloucester-based Archie Matthews Trust for a special day of "fun, fitness and fundraising".Mr Hampton said his friend Jay, who he met through the gym, "sadly took his own life" and that "members of the gym wanted to do something in his memory to help raise awareness".Alongside the Archie Matthews Trust, they are fundraising to support the gaps in young men's mental health. If you are affected by any of the issues raised in this story you can visit BBC Action Line. Mr Hampton's racing wheelchair will be on a long roller in the gym, which "really will be a challenge," he said. With no hills to roll down, and continually having to use his hands, he said "you wouldn't normally do this". "So I've no idea how long it's going to take me, but it will be hours"."Jay would say I'm crazy but would really encourage me if he knew what I was doing. He would always say in the gym 'come on Les, just one more'."The team is hoping to raise about £2,000. Other challenges gym members are attempting on the day include a marathon swim, a charity spin and a community challenge to try and push a sledge down a 15m (about 50ft) track, for 3,500 lengths, wearing 50kg (110 lb).Gym manager Jo Allen said: "It's going to be tough and we'll need all the help we can get from members," many of whom were friends with said men's mental health needed a lot of support as it was a big problem. "In gyms, behind the testosterone and heavy weights being lifted, you'll find a lot of young lads who might suffer, but it's something we definitely don't talk about enough." 'Plug support gaps' Steve Matthews, chairman of the Archie Matthews Trust, which is named after his son, will be at the challenge with his wife and Archie's mum, Steph."Archie was a wonderful lad. Everyone who met him would have said he was a bright confident funny guy with lots of friends," Mr Matthew's said."He was a big lad. But behind that he did struggle with his mental health. He had ADHD, was autistic and struggled with anxiety, then later depression. He sadly took his own life last year," he Matthew's said they set up the trust to "plug some of the support gaps we found through Archie's experience".They hope to help young men and boys - particularly in Gloucestershire - and particularly those with neurodivergence, as they are at a high risk of mental health issues and suicide, he said."Jays story really resonated with us and we're just trying to help where we can so others don't have to go through what we did," he added.
Daily Mail
7 hours ago
- Daily Mail
Experts warn millions diagnosed with ADHD may not have it - they're likely suffering another, common disorder instead
A major new analysis has fueled concerns over the accuracy of tests that diagnose ADHD, suggesting many of those told they have the disorder are in fact suffering depression. Scientists from Scandinavia and Brazil analysed common methods of diagnosing adult ADHD described in nearly 300 medical studies. Many of these diagnostic tests are currently used by doctors in the UK to spot the condition. The findings showed that in nearly half the studies, the scientists failed to rule out other causes of ADHD-like symptoms, such as depression. This means, they concluded, that the diagnostic test used may be unreliable, and therefore providing inaccurate results in the real world. 'You don't actually know if subjects have other mental disorders such as depression or schizophrenia,' the experts wrote in their report. The latest findings come amid a rapid rise in adult ADHD diagnoses in the UK, with cases rising 20-fold over the last two decades. It's a phenomenon that has raised the concern of some of the country's top psychologists and spurred a NHS investigation, launched in March. Experts have warned that rogue private clinics are over-diagnosing the condition and have questioned the widespread prescribing of powerful stimulant drugs to treat it. In the latest analysis, scientists found that a psychiatrist or psychologist made the diagnosis in only 35 per cent of ADHD cases examined. Adults in the UK can only be formally assessed for ADHD on the NHS by a psychiatrist, psychologist or specialist ADHD nurse. In some cases discovered by the researchers, it was explicitly stated that the assessment and diagnosis of ADHD was made by subjects themselves. One patient was reported to have reached their diagnosis with the help of a computer, the researchers explained. 'In psychiatry, we really need that all diagnoses, not just ADHD, are made with the same uniform criteria and by trained professionals,' said co-author of the study, consultant psychiatrist Dr Julie Nordgaard from the University of Copenhagen. 'Otherwise, we cannot rely on the results or compare them across studies. 'Especially in a situation where a diagnosis such as ADHD in adults is increasing, we need to be very thorough and have a solid foundation. 'Otherwise, we risk too many people getting a wrong diagnosis and not being able to give them the most effective treatment. 'Or they risk receiving unnecessary treatment that causes side-effects.' Symptoms of depression can often mimic those of ADHD, research has shown. A neurodevelopmental disorder, ADHD affects concentration, impulse control and activity levels. Common symptoms include restlessness, distractibility, forgetfulness, difficulty following instructions or managing time, and making impulsive decisions. Depression, which affects roughly one in six adults in the UK, can look remarkably similar. Those with the mood disorder often experience poor concentration, low energy and disturbed sleep. Both ADHD and depression can also cause changes in appetite, restlessness and irritability as well as difficulty initiating and completing tasks. Schizophrenia, though less common—affecting just one per cent of the UK population —can also resemble ADHD in some cases. Traditionally characterised by psychotic symptoms like hallucinations and delusions, schizophrenia can also cause attention problems, particularly in its early stages. The researchers concluded it's impossible to know which disorders and symptoms were actually being affected by the treatments investigated in the trials. 'This makes the research results from many of these clinical trials difficult to utilise,' said associate professor at the University of Copenhagen Dr Mads Gram Henrikson. The study comes just months after the latest NHS figures revealed more than 549,000 people in England were waiting for an ADHD assessment at the end of March 2025—up from 416,000 the previous year. Of those currently waiting for an assessment, around 304,000 had been waiting at least a year—and 144,000 for two years or more, as NHS services struggle to keep up with spiraling demand. More than two-thirds (382,000) were aged between five and 24. Last year a MailOnline investigation revealed that doctors were dishing out powerful ADHD drugs at 10-times the rate in some parts of England than others. NHS data shows as many as one in 100 people in some areas are taking ADHD medications, compared to just one in 1,000 in nearby regions. Commenting on the findings, experts warned of over-diagnosis and 'mass-prescribing' could be putting public health at risk. University College London psychiatrist Professor Joanna Moncrieff, a vocal critic of medication overuse, said ADHD diagnosis is 'incredibly subjective'. 'One psychiatrist may think almost everyone has it, while another thinks very few do,' she said. 'We all have ADHD symptoms to some extent.' She added that private clinics are often quicker to diagnose than the NHS, making a diagnosis more likely in the independent sector. Professor Moncrieff said patients were increasingly demanding an ADHD diagnosis as the 'answer' to problems they are experiencing in areas like their work. 'This concept of ADHD has got out there and everyone is reinterpreting their difficulties in the light this new idea, 'I'm not bored and don't like my job, I have ADHD',' she said. 'Stimulants make people feel good, they make them feel confident, they make people feel a little bit euphoric, energetic, so of course people are going to be rating themselves as doing better.' Rising interest in ADHD is thought to be fueled in part by celebrities sharing their diagnoses — including Katie Price, Love Island's Olivia Attwood, Sheridan Smith and former Bake Off host Sue Perkins. Attwood said it caused 'a lot of stress' in her teens, while Price said it explained why she never felt there would be 'consequences' for her actions. Perkins said the diagnosis made 'everything make sense'. Social media has also been blamed, with users praising ADHD meds for calming them and boosting focus. NHS prescriptions have doubled in six years to 230,000, with the sharpest rise—nearly 60 per cent in a year—among women in their late 20s and early 30s. Use among 25 to 39-year-olds has increased five-fold since 2015. In response, NHS England launched a taskforce to assess the scale of the condition. ADHD is also behind a surge in disability benefit claims. One in five now relate to behavioural conditions, with over 52,000 adults—mostly aged 16 to 29—listing ADHD as their main condition.
